ALFA Filings
Every announcement, straight from the exchange
Every Mankind Pharma credit rating announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
ICRA reaffirmed Mankind Pharma's AA+ ratings and assigned A1+ for ₹6,850 Crore in debt instruments. The stable outlook reflects the company's robust credit profile.
Mankind Pharma Limited has been assigned credit ratings by CARE Ratings Limited for ₹1,000 Crore in bank facilities. The long-term and short-term facilities received 'CARE AA+; Stable' and 'CARE A1+' ratings respectively. This assignment reflects the company's creditworthiness and stable financial outlook.